Cladribine for mastocytosis: benefits and risks

Blood. 2015 Aug 20;126(8):931-2. doi: 10.1182/blood-2015-06-649525.

Abstract

In this issue of Blood, Barete et al report the safety and efficacy of cladribine in 68 adult patients with mastocytosis.

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Cladribine / therapeutic use*
  • Female
  • Humans
  • Male
  • Mastocytosis / drug therapy*

Substances

  • Antineoplastic Agents
  • Cladribine